Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.
Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V. Tosco A, et al. Among authors: lusa s. Cell Death Differ. 2016 Aug;23(8):1380-93. doi: 10.1038/cdd.2016.22. Epub 2016 Apr 1. Cell Death Differ. 2016. PMID: 27035618 Free PMC article. Clinical Trial.
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.
Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V. Tosco A, et al. Among authors: lusa s. Cell Death Differ. 2017 Jul;24(7):1305. doi: 10.1038/cdd.2016.43. Epub 2016 Jul 22. Cell Death Differ. 2017. PMID: 27447111 Free PMC article.
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.
Campani V, Salzano G, Lusa S, De Rosa G. Campani V, et al. Among authors: lusa s. Nanomaterials (Basel). 2016 Jul 9;6(7):131. doi: 10.3390/nano6070131. Nanomaterials (Basel). 2016. PMID: 28335259 Free PMC article. Review.
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.
Kopecka J, Porto S, Lusa S, Gazzano E, Salzano G, Pinzòn-Daza ML, Giordano A, Desiderio V, Ghigo D, De Rosa G, Caraglia M, Riganti C. Kopecka J, et al. Among authors: lusa s. Oncotarget. 2016 Apr 12;7(15):20753-72. doi: 10.18632/oncotarget.8012. Oncotarget. 2016. PMID: 26980746 Free PMC article.
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.
Ieranò C, Portella L, Lusa S, Salzano G, D'Alterio C, Napolitano M, Buoncervello M, Macchia D, Spada M, Barbieri A, Luciano A, Barone MV, Gabriele L, Caraglia M, Arra C, De Rosa G, Scala S. Ieranò C, et al. Among authors: lusa s. Nanoscale. 2016 Apr 14;8(14):7562-71. doi: 10.1039/c5nr06335c. Nanoscale. 2016. PMID: 26983756
57 results